Skip to main content
NewslettersWatchlist

Maravai Lifesciences Holdings Inc Cl A(MRVI-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low10.74
Day High10.97
Open:10.92
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
Motley Fool
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript
Motley Fool
Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript
Barchart
Stock Index Futures Plunge as China Trade Data Disappoints, Moody's Downgrades U.S. Banks
Motley Fool
Maravai LifeSciences (MRVI) Q2 2023 Earnings Call Transcript
Motley Fool
Maravai LifeSciences (MRVI) Q1 2023 Earnings Call Transcript
Motley Fool
2 Top Biotech Stocks to Buy In March and Hold Forever
Motley Fool
Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential
Motley Fool
Maravai LifeSciences (MRVI) Q4 2022 Earnings Call Transcript
Motley Fool
2 Healthcare Companies That Could Be Acquired Within 5 Years
Motley Fool
3 Great Growth Stocks Down 20% or More to Buy Now
Motley Fool
3 Biopharma Stocks That Could Help Make You a Fortune
Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Motley Fool
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
Motley Fool
This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why
Motley Fool
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2022 Earnings Call Transcript
Motley Fool
3 of the Best Bear Market Buys for August
Globe Newswire
CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results
Globe Newswire
Maravai Lifesciences Reports Second Quarter 2022 Financial Results
Motley Fool
3 Beaten-Down Stocks That Could Soar in the Second Half of 2022
Globe Newswire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022
Globe Newswire
TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team
Globe Newswire
TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense
Globe Newswire
Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule
Motley Fool
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2022 Earnings Call Transcript
Globe Newswire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022
Motley Fool
Forget Robinhood and Buy These 2 Growth Stocks Instead
Motley Fool
1 Biotech Stock Investors Should Know About
Globe Newswire
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
Motley Fool
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2021 Earnings Call Transcript
Globe Newswire
Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance
Motley Fool
3 Biotech Stocks That Could Deliver 5X Gains by 2030

Profile

Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.